HIGHLIGHTS
- who: Fernando Rivadeneira from the Department of Internal Medicine, Erasmus MC University Medical Center, Rotterdam, Netherlands Sciences, India have published the paper: Genomic Medicine: Lessons Learned From Monogenic and Complex Bone Disorders, in the Journal: (JOURNAL)
- what: Although the current model was genetically identical to human OI type V, it showed additional clinical manifestations.
- future: Investigations are needed to establish whether GPC6 or DAAM2 truly represent a suitable drug_target for osteoporosis. This way systems biology approaches guided by genomic studies can help to improve decisionmaking in pharmaceutical development in the search for novel . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.